Abstract

In addition to the increasing risk of abdominal aortic aneurysm (AAA) with age, the overall incidence of AAA is increasing, especially small asymptomatic aneurysms. There is no systematic approach to screening at present, AAA usually being identified during imaging studies for unrelated problems. The aneurysm diameter is the best indicator for rupture risk and the necessity of surgical intervention. Drugs have been demonstrated to slow the growth of AAAs, thus delaying surgery. Animal studies with doxycycline have shown positive results. Human trials have been started to gauge the dose necessary to slow the growth of AAAs. If doxycycline proves to be effective in this, various measures will need to be addressed, including widespread screening.

Original languageEnglish (US)
Pages (from-to)240-243
Number of pages4
JournalGefasschirurgie
Volume7
Issue number4
DOIs
StatePublished - Dec 1 2002

Fingerprint

Doxycycline
Abdominal Aortic Aneurysm
Aneurysm
Growth
Rupture
Incidence
Pharmaceutical Preparations

Keywords

  • Abdominal aortic aneurysm (AAA)
  • Diameter
  • Doxycycline
  • Imaging studies
  • Risk of rupture surgery

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Doxycycline as a means of decreasing abdominal aortic aneurysm growth : Will it work? / Baxter, Bernard Timothy; Johanning, Jason M.

In: Gefasschirurgie, Vol. 7, No. 4, 01.12.2002, p. 240-243.

Research output: Contribution to journalReview article

@article{68712d233d7342929b3a9985816cc916,
title = "Doxycycline as a means of decreasing abdominal aortic aneurysm growth: Will it work?",
abstract = "In addition to the increasing risk of abdominal aortic aneurysm (AAA) with age, the overall incidence of AAA is increasing, especially small asymptomatic aneurysms. There is no systematic approach to screening at present, AAA usually being identified during imaging studies for unrelated problems. The aneurysm diameter is the best indicator for rupture risk and the necessity of surgical intervention. Drugs have been demonstrated to slow the growth of AAAs, thus delaying surgery. Animal studies with doxycycline have shown positive results. Human trials have been started to gauge the dose necessary to slow the growth of AAAs. If doxycycline proves to be effective in this, various measures will need to be addressed, including widespread screening.",
keywords = "Abdominal aortic aneurysm (AAA), Diameter, Doxycycline, Imaging studies, Risk of rupture surgery",
author = "Baxter, {Bernard Timothy} and Johanning, {Jason M}",
year = "2002",
month = "12",
day = "1",
doi = "10.1007/s00772-002-0237-4",
language = "English (US)",
volume = "7",
pages = "240--243",
journal = "Gefasschirurgie",
issn = "0948-7034",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Doxycycline as a means of decreasing abdominal aortic aneurysm growth

T2 - Will it work?

AU - Baxter, Bernard Timothy

AU - Johanning, Jason M

PY - 2002/12/1

Y1 - 2002/12/1

N2 - In addition to the increasing risk of abdominal aortic aneurysm (AAA) with age, the overall incidence of AAA is increasing, especially small asymptomatic aneurysms. There is no systematic approach to screening at present, AAA usually being identified during imaging studies for unrelated problems. The aneurysm diameter is the best indicator for rupture risk and the necessity of surgical intervention. Drugs have been demonstrated to slow the growth of AAAs, thus delaying surgery. Animal studies with doxycycline have shown positive results. Human trials have been started to gauge the dose necessary to slow the growth of AAAs. If doxycycline proves to be effective in this, various measures will need to be addressed, including widespread screening.

AB - In addition to the increasing risk of abdominal aortic aneurysm (AAA) with age, the overall incidence of AAA is increasing, especially small asymptomatic aneurysms. There is no systematic approach to screening at present, AAA usually being identified during imaging studies for unrelated problems. The aneurysm diameter is the best indicator for rupture risk and the necessity of surgical intervention. Drugs have been demonstrated to slow the growth of AAAs, thus delaying surgery. Animal studies with doxycycline have shown positive results. Human trials have been started to gauge the dose necessary to slow the growth of AAAs. If doxycycline proves to be effective in this, various measures will need to be addressed, including widespread screening.

KW - Abdominal aortic aneurysm (AAA)

KW - Diameter

KW - Doxycycline

KW - Imaging studies

KW - Risk of rupture surgery

UR - http://www.scopus.com/inward/record.url?scp=0036935618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036935618&partnerID=8YFLogxK

U2 - 10.1007/s00772-002-0237-4

DO - 10.1007/s00772-002-0237-4

M3 - Review article

VL - 7

SP - 240

EP - 243

JO - Gefasschirurgie

JF - Gefasschirurgie

SN - 0948-7034

IS - 4

ER -